Response and survival in unresectable in-transit metastatic melanoma according to treatment strategy.
Saved in:
| Title: | Response and survival in unresectable in-transit metastatic melanoma according to treatment strategy. |
|---|---|
| Authors: | Boreel C; Scientific Bureau, Dutch Institute for Clinical Auditing, Rijnsburgerweg 10, Leiden 2333AA, the Netherlands; Department of Medical Oncology, University Medical Centre Utrecht, Utrecht University, Heidelberglaan 100, Utrecht 3584CX, the Netherlands. Electronic address: c.d.m.boreel-2@umcutrecht.nl., de Ruijter J; Department of Medical Oncology, University Medical Centre Utrecht, Utrecht University, Heidelberglaan 100, Utrecht 3584CX, the Netherlands., van Not O; Department of Dermatology, Leiden University Medical Centre, Albinusdreef 2, Leiden 2333ZA, the Netherlands., Bloem M; Scientific Bureau, Dutch Institute for Clinical Auditing, Rijnsburgerweg 10, Leiden 2333AA, the Netherlands; Department of Biomedical Data Sciences, Leiden University Medical Centre, Einthovenweg 20, Leiden 2333ZC, the Netherlands; Department of Surgical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam 1066CX, the Netherlands., Been L; Department of Surgical Oncology, University Medical Centre Groningen, University of Groningen, Hanzeplein 1, Groningen 9713GZ, the Netherlands., Aarts M; Department of Medical Oncology, GROW School for Oncology and Reproduction, Maastricht University Medical Centre+, P. Debyelaan 25, Maastricht 6229 HX, the Netherlands., van den Berkmortel F; Department of Medical Oncology, Zuyderland Medical Centre Sittard, Dr. H. van der Hoffplein 1, Sittard-Geleen 6162BG, the Netherlands., Blank C; Division of Medical Oncology, The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam 1066CX, the Netherlands; Division of Immunology, Amsterdam, The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam 1066CX, the Netherlands; Department of Hematology and Oncology, University Clinic Regensburg (UKR), Regensburg, Germany; Division of Melanoma and Sarcoma, European Institute of Oncology (IEO), Milano, Italy; Department of Medical Oncology, Leiden University Medical Centre, Albinusdreef 2, Leiden 2333ZA, the Netherlands., Boers-Sonderen M; Department of Medical Oncology, Radboud University Medical Centre, Geert Grooteplein Zuid 10, Nijmegen 6525GA, the Netherlands., Bonenkamp H; Department of Surgery, Radboud University Medical Centre, Geert Grooteplein Zuid 10, Nijmegen 6525GA, the Netherlands., de Groot JW; Isala Oncology Centre, Isala, Dokter van Heesweg 2, Zwolle 8025AB, the Netherlands., Grünhagen D; Department of Surgical Oncology, Erasmus Medical Centre, Dr. Molewaterplein 40, Rotterdam 3015GD, the Netherlands., Haanen J; Division of Medical Oncology, The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam 1066CX, the Netherlands; Melanoma Clinic, Centre Hospitalier Universitaire Vaudois, Rue du Bugnon 21, Lausanne CH-1011, Switzerland; Department of Medical Oncology, Leiden University Medical Centre, Albinusdreef 2, Leiden 2333ZA, the Netherlands., Hilde Jalving M; Department of Medical Oncology, University Medical Centre Groningen, University of Groningen, Hanzeplein 1, Groningen 9713GZ, the Netherlands., Piersma D; Department of Internal Medicine, Medisch Spectrum Twente, Koningsplein 1, Enschede 7512KZ, the Netherlands., Rikhof B; Department of Internal Medicine, Frisius MC, Henri Dunantweg 2, Leeuwarden 8934AD, the Netherlands., Boer MS; Department of Internal Medicine, Amphia Hospital, Molengracht 21, Breda 4818CK, the Netherlands., van der Veldt A; Department of Medical Oncology and Radiology & Nuclear Medicine, Erasmus Medical Centre, Dr. Molewaterplein 40, Rotterdam 3015GD, the Netherlands., Simkens L; Department of Internal Medicine, Maxima Medical Centre, De Run 4600, Eindhoven 5504DB, the Netherlands., Wouters M; Scientific Bureau, Dutch Institute for Clinical Auditing, Rijnsburgerweg 10, Leiden 2333AA, the Netherlands; Department of Biomedical Data Sciences, Leiden University Medical Centre, Einthovenweg 20, Leiden 2333ZC, the Netherlands; Department of Surgical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam 1066CX, the Netherlands., Kapiteijn E; Department of Medical Oncology, Leiden University Medical Centre, Albinusdreef 2, Leiden 2333ZA, the Netherlands., van den Eertwegh F; Department of Medical Oncology, Amsterdam UMC, VU University Medical Centre, Cancer Centre Amsterdam, De Boelelaan 1118, Amsterdam 1081HZ, the Netherlands., Suijkerbuijk K; Department of Medical Oncology, University Medical Centre Utrecht, Utrecht University, Heidelberglaan 100, Utrecht 3584CX, the Netherlands. |
| Source: | European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2026 Jun 21; Vol. 244, pp. 116889. Date of Electronic Publication: 2026 Jun 21. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42335571 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Response and survival in unresectable in-transit metastatic melanoma according to treatment strategy. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Boreel+C%22">Boreel C</searchLink>; Scientific Bureau, Dutch Institute for Clinical Auditing, Rijnsburgerweg 10, Leiden 2333AA, the Netherlands; Department of Medical Oncology, University Medical Centre Utrecht, Utrecht University, Heidelberglaan 100, Utrecht 3584CX, the Netherlands. Electronic address: c.d.m.boreel-2@umcutrecht.nl.<br /><searchLink fieldCode="AU" term="%22de+Ruijter+J%22">de Ruijter J</searchLink>; Department of Medical Oncology, University Medical Centre Utrecht, Utrecht University, Heidelberglaan 100, Utrecht 3584CX, the Netherlands.<br /><searchLink fieldCode="AU" term="%22van+Not+O%22">van Not O</searchLink>; Department of Dermatology, Leiden University Medical Centre, Albinusdreef 2, Leiden 2333ZA, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Bloem+M%22">Bloem M</searchLink>; Scientific Bureau, Dutch Institute for Clinical Auditing, Rijnsburgerweg 10, Leiden 2333AA, the Netherlands; Department of Biomedical Data Sciences, Leiden University Medical Centre, Einthovenweg 20, Leiden 2333ZC, the Netherlands; Department of Surgical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam 1066CX, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Been+L%22">Been L</searchLink>; Department of Surgical Oncology, University Medical Centre Groningen, University of Groningen, Hanzeplein 1, Groningen 9713GZ, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Aarts+M%22">Aarts M</searchLink>; Department of Medical Oncology, GROW School for Oncology and Reproduction, Maastricht University Medical Centre+, P. Debyelaan 25, Maastricht 6229 HX, the Netherlands.<br /><searchLink fieldCode="AU" term="%22van+den+Berkmortel+F%22">van den Berkmortel F</searchLink>; Department of Medical Oncology, Zuyderland Medical Centre Sittard, Dr. H. van der Hoffplein 1, Sittard-Geleen 6162BG, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Blank+C%22">Blank C</searchLink>; Division of Medical Oncology, The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam 1066CX, the Netherlands; Division of Immunology, Amsterdam, The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam 1066CX, the Netherlands; Department of Hematology and Oncology, University Clinic Regensburg (UKR), Regensburg, Germany; Division of Melanoma and Sarcoma, European Institute of Oncology (IEO), Milano, Italy; Department of Medical Oncology, Leiden University Medical Centre, Albinusdreef 2, Leiden 2333ZA, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Boers-Sonderen+M%22">Boers-Sonderen M</searchLink>; Department of Medical Oncology, Radboud University Medical Centre, Geert Grooteplein Zuid 10, Nijmegen 6525GA, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Bonenkamp+H%22">Bonenkamp H</searchLink>; Department of Surgery, Radboud University Medical Centre, Geert Grooteplein Zuid 10, Nijmegen 6525GA, the Netherlands.<br /><searchLink fieldCode="AU" term="%22de+Groot+JW%22">de Groot JW</searchLink>; Isala Oncology Centre, Isala, Dokter van Heesweg 2, Zwolle 8025AB, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Grünhagen+D%22">Grünhagen D</searchLink>; Department of Surgical Oncology, Erasmus Medical Centre, Dr. Molewaterplein 40, Rotterdam 3015GD, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Haanen+J%22">Haanen J</searchLink>; Division of Medical Oncology, The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam 1066CX, the Netherlands; Melanoma Clinic, Centre Hospitalier Universitaire Vaudois, Rue du Bugnon 21, Lausanne CH-1011, Switzerland; Department of Medical Oncology, Leiden University Medical Centre, Albinusdreef 2, Leiden 2333ZA, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Hilde+Jalving+M%22">Hilde Jalving M</searchLink>; Department of Medical Oncology, University Medical Centre Groningen, University of Groningen, Hanzeplein 1, Groningen 9713GZ, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Piersma+D%22">Piersma D</searchLink>; Department of Internal Medicine, Medisch Spectrum Twente, Koningsplein 1, Enschede 7512KZ, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Rikhof+B%22">Rikhof B</searchLink>; Department of Internal Medicine, Frisius MC, Henri Dunantweg 2, Leeuwarden 8934AD, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Boer+MS%22">Boer MS</searchLink>; Department of Internal Medicine, Amphia Hospital, Molengracht 21, Breda 4818CK, the Netherlands.<br /><searchLink fieldCode="AU" term="%22van+der+Veldt+A%22">van der Veldt A</searchLink>; Department of Medical Oncology and Radiology & Nuclear Medicine, Erasmus Medical Centre, Dr. Molewaterplein 40, Rotterdam 3015GD, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Simkens+L%22">Simkens L</searchLink>; Department of Internal Medicine, Maxima Medical Centre, De Run 4600, Eindhoven 5504DB, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Wouters+M%22">Wouters M</searchLink>; Scientific Bureau, Dutch Institute for Clinical Auditing, Rijnsburgerweg 10, Leiden 2333AA, the Netherlands; Department of Biomedical Data Sciences, Leiden University Medical Centre, Einthovenweg 20, Leiden 2333ZC, the Netherlands; Department of Surgical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam 1066CX, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Kapiteijn+E%22">Kapiteijn E</searchLink>; Department of Medical Oncology, Leiden University Medical Centre, Albinusdreef 2, Leiden 2333ZA, the Netherlands.<br /><searchLink fieldCode="AU" term="%22van+den+Eertwegh+F%22">van den Eertwegh F</searchLink>; Department of Medical Oncology, Amsterdam UMC, VU University Medical Centre, Cancer Centre Amsterdam, De Boelelaan 1118, Amsterdam 1081HZ, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Suijkerbuijk+K%22">Suijkerbuijk K</searchLink>; Department of Medical Oncology, University Medical Centre Utrecht, Utrecht University, Heidelberglaan 100, Utrecht 3584CX, the Netherlands. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229005373%22">European journal of cancer (Oxford, England : 1990)</searchLink> [Eur J Cancer] 2026 Jun 21; Vol. 244, pp. 116889. <i>Date of Electronic Publication: </i>2026 Jun 21. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Science+Ltd%22">Elsevier Science Ltd </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>9005373 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1879-0852 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2209598049%22">09598049 </searchLink><i>NLM ISO Abbreviation: </i>Eur J Cancer <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42335571 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.ejca.2026.116889 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 116889 Titles: – TitleFull: Response and survival in unresectable in-transit metastatic melanoma according to treatment strategy. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Boreel C – PersonEntity: Name: NameFull: de Ruijter J – PersonEntity: Name: NameFull: van Not O – PersonEntity: Name: NameFull: Bloem M – PersonEntity: Name: NameFull: Been L – PersonEntity: Name: NameFull: Aarts M – PersonEntity: Name: NameFull: van den Berkmortel F – PersonEntity: Name: NameFull: Blank C – PersonEntity: Name: NameFull: Boers-Sonderen M – PersonEntity: Name: NameFull: Bonenkamp H – PersonEntity: Name: NameFull: de Groot JW – PersonEntity: Name: NameFull: Grünhagen D – PersonEntity: Name: NameFull: Haanen J – PersonEntity: Name: NameFull: Hilde Jalving M – PersonEntity: Name: NameFull: Piersma D – PersonEntity: Name: NameFull: Rikhof B – PersonEntity: Name: NameFull: Boer MS – PersonEntity: Name: NameFull: van der Veldt A – PersonEntity: Name: NameFull: Simkens L – PersonEntity: Name: NameFull: Wouters M – PersonEntity: Name: NameFull: Kapiteijn E – PersonEntity: Name: NameFull: van den Eertwegh F – PersonEntity: Name: NameFull: Suijkerbuijk K IsPartOfRelationships: – BibEntity: Dates: – D: 21 M: 06 Text: 2026 Jun 21 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1879-0852 Numbering: – Type: volume Value: 244 Titles: – TitleFull: European journal of cancer (Oxford, England : 1990) Type: main |
| ResultId | 1 |